Lawmakers press Eli Lilly for China drug trials tied to military-linked hospitals

Eli Lilly confirmed it conducted clinical trials in China at facilities connected to military institutions and locations in Xinjiang, according to statements made to House lawmakers. The House Energy and Commerce Committee launched an investigation into the trials, requesting documents and information from the company. Eli Lilly stated the trials followed applicable regulations and were designed to generate safety and efficacy data for drugs being studied in those regions. The company did not specify which drugs were tested or the number of trial participants involved.

Next story